Literature DB >> 7617797

Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients.

A J Hiltunen1, P Lafolie, J Martel, E C Ottosson, L O Boreus, O Beck, S Borg, P Hjemdahl.   

Abstract

Two rating scales, which were originally developed for measurements of objective and subjective signs of opiate withdrawal, were used to evaluate potential estimates (correlates) of methadone effects in relation to plasma methadone concentrations. Patients participating in our regular methadone maintenance treatment project were studied during 24 h after the intake of the daily methadone dose. Methadone concentrations in plasma were compared to the subjective (estimated by the patients) and objective (estimated by the investigator) signs of the drug effects before, and 2.5, 5, 9 and 24 h after intake of methadone. Some new items possibly related to rising methadone concentrations were added to the subjective scale. Results indicated that, for subjective ratings, the majority of the items investigated corresponded well with the plasma methadone concentrations. The most significant associations were found for the following items: low psychomotor speed, alertness, running nose, yawning and anxiety. For objective ratings, only the items rhinorrhea, piloerection and signs of anxiety were significantly associated with the methadone concentrations. These rating scales may, together with plasma methadone determinations, be of considerable value when making dose adjustments for methadone maintenance patients. Further work is, however, needed to establish concentration-effect relationships.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7617797     DOI: 10.1007/BF02245829

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  6 in total

1.  The use of plasma levels to optimize methadone maintenance treatment.

Authors:  N Loimer; R Schmid
Journal:  Drug Alcohol Depend       Date:  1992-08       Impact factor: 4.492

2.  Monitoring of plasma methadone: intercorrelation between immunoassay and gas chromatography-mass spectrometry.

Authors:  O Beck; L O Boreus; S Borg; G Jacobsson; P Lafolie; M Stensiö
Journal:  Ther Drug Monit       Date:  1990-09       Impact factor: 3.681

3.  Opiate withdrawal as measured by the Addiction Research Center Inventory (ARCI).

Authors:  C A Haertzen; M J Meketon
Journal:  Dis Nerv Syst       Date:  1968-07

4.  Addiction Research Center Inventory (ARCI): development of a general drug estimation scale.

Authors:  C A Haertzen
Journal:  J Nerv Ment Dis       Date:  1965-09       Impact factor: 2.254

5.  Methadone maintenance: plasma levels and therapeutic outcome.

Authors:  J Holmstrand; E Anggård; L M Gunne
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

6.  Two new rating scales for opiate withdrawal.

Authors:  L Handelsman; K J Cochrane; M J Aronson; R Ness; K J Rubinstein; P D Kanof
Journal:  Am J Drug Alcohol Abuse       Date:  1987       Impact factor: 3.829

  6 in total
  3 in total

1.  Affective and neuroendocrine effects of withdrawal from chronic, long-acting opiate administration.

Authors:  Kathryn L Hamilton; Andrew C Harris; Jonathan C Gewirtz
Journal:  Brain Res       Date:  2013-09-26       Impact factor: 3.252

2.  Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre.

Authors:  Jaroon Jittiwutikarn; Robert Ali; Jason M White; Felix Bochner; Andrew A Somogyi; David J R Foster
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

3.  Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of methadone in a sample of Iranian (mazandarani) opiate users undergoing methadone maintenance treatment.

Authors:  Mohammad-Reza Shiran; Rasa Hosseinzadeh; Abolhassan Hamidikenari; Mehran Zarghami; Nargess Lamsehchi; Mohammad-Reza Rafati
Journal:  Iran J Psychiatry Behav Sci       Date:  2011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.